Quist, Sara W. https://orcid.org/0000-0003-3871-4239
Paulissen, Jeroen H. J.
Lunk, Izabella
Carrasco, Joao
Woudstra, Marrit A.
Pochopien, Michal
Nikodem, Mateusz
Crossan, Catriona
Amarakoon, Sankha
van Asten, Freekje
Postma, Maarten J.
Funding for this research was provided by:
Pharmaceuticals Bayer
Article History
Received: 2 April 2025
Accepted: 30 April 2025
First Online: 7 June 2025
Declarations
:
: Sara Quist and Jeroen Paulissen were employees of Asc Academics during this research, which was funded by Bayer. Jeroen Paulissen is now employed by Daiichi Sankyo Nederland B.V. Izabella Lunk, Joao Carrasco, and Marrit Woudstra were an employee of Bayer during the conduct of this research. Michal Pochopien was an employee of Clever Access the conduct of this research, which was funded by Bayer. Mateusz Nikodem and Catriona Crossan were employees of Putnam during the conduct of this research, which was funded by Bayer. Sankha Amarakoon conducted consultancy work for Bayer, Novartis, Horuspharma, and Roche. Freekje van Asten has no conflict of interest to declare. Maarten Postma has received grants and honoraria from various pharmaceutical companies (unrelated to this work) and holds stocks and advisory roles in PAG BV, Health-Ecore, and Asc Academics (all in Groningen, the Netherlands).
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.